MIGLIETTA, FEDERICA

MIGLIETTA, FEDERICA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 67 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study 2025 Miglietta, F.Collesei, A.Griguolo, G.Massa, D.Fassan, M.Dei Tos, A. P.Dieci, M. V.Guarneri, V. + ESMO OPEN - -
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer 2025 Dieci, Maria VittoriaMiglietta, FedericaMassa, DavideGuarneri, Valentina + JAMA ONCOLOGY - -
ALLSTAR: inference of reliAble causaL ruLes between Somatic muTAtions and canceR phenotypes 2024 Simionato, DarioCollesei, AntonioMiglietta, FedericaVandin, Fabio BIOINFORMATICS - -
Breast cancer biological characterization - Evaluation of the prognostic and/or predictive role of clinical, pathological and molecular biomarkers to dissect breast cancer heterogeneity: focus on estrogen-low breast cancer 2024 MIGLIETTA, FEDERICA - - -
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 2024 Bottosso, MicheleDieci, Maria VittoriaMiglietta, FedericaBonanno, LauraGuarneri, ValentinaGriguolo, GaiaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project 2024 Miglietta, Federica + CANCER TREATMENT REVIEWS - -
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 2024 Miglietta, FedericaGuarneri, Valentina + THE BREAST - -
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer 2024 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, ValentinaGriguolo, Gaia + CLINICAL CANCER RESEARCH - -
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer 2024 Massa, DavideGriguolo, GaiaMiglietta, FedericaSchiavi, FrancescaFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + JOURNAL OF THE NATIONAL CANCER INSTITUTE - -
Managing sexual health challenges in breast cancer survivors: A comprehensive review 2024 Miglietta, FedericaGuarneri, Valentina + BREAST - -
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 2024 Dieci, Maria VittoriaGriguolo, GaiaMiglietta, FedericaGuarneri, Valentina + JOURNAL OF THE NATIONAL CANCER INSTITUTE - -
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer 2024 Dieci, Maria VittoriaMiglietta, Federica + CANCER TREATMENT REVIEWS - -
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy 2023 Edoardo Vincenzo SavarinoIlaria PatuzziFabiana ZingoneFederica MigliettaGaia GriguoloMatteo FassanValentina GuarneriMaria Vittoria Dieci + THE ONCOLOGIST - -
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - -
How can we refine the prognostic stratification of triple-negative breast cancer? 2023 Miglietta, FedericaDieci, Maria Vittoria EXPERT REVIEW OF ANTICANCER THERAPY - -
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + JOURNAL OF CLINICAL ONCOLOGY - -
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 2023 Miglietta, FDieci, M VConte, P FGuarneri, V + CANCER TREATMENT REVIEWS - -
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleDei Tos, Angelo PaoloGuarneri, ValentinaDieci, Maria VittoriaFassan, Matteo + JOURNAL OF CLINICAL PATHOLOGY - -